The way forward for a everlasting ban on gross sales stays unsure. Apple nonetheless has authorized avenues left the place it will probably attraction in opposition to it, however on the identical time, the corporate additionally appears to be prepared with an alternate route if issues do not go nicely. But the choice to ship its newest smartwatches with out one of many prized wellness options is a serious transfer. Apple first launched a blood oxygen stage measurement system on the Series 6 and has continued providing it on all subsequent smartwatches after engaged on the tech for almost a decade.
Masimo alleges that Apple met the corporate about its work on wearable pulse oximetry tech even earlier than the primary technology Apple smartwatch was launched. But nothing got here out of that assembly. Later, the company allegedly poached Masimo’s talent and even used its tech with none due licensing deal or authorized allow. On the opposite hand, Apple has rejected Masimo’s claims and has even scored authorized victories over a number of the objections made by the medical tech firm.
It could be attention-grabbing to see whether or not the dispute will spill over to the following technology of Apple smartwatches. In late 2024, the Apple Watch X, aka Series, is rumored to get a recent design and a few new well being options, together with non-invasive blood sugar stage evaluation. So far, no mainstream rival resembling Samsung has managed to crack the code and ship it commercially, regardless of years’ value of analysis into miniaturizing and refining it.
